Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDPT ZEN119: Zenapax in Newly Diagnosed Type 1 Diabetes
NCT00198146Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Jul 2000
- Primary completion
- Feb 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daclizumab in type 1 diabetes mellitus (T1D), sponsored by Indiana University School of Medicine. Started Jul 2000; status: completed.
02
Drugs
daclizumab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00198146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198146.